<p><b>Abbrevation:</b> HCC, hepatocellular carcinoma; mRECIST, modified Response Evaluation Criteria in Solid Tumors; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.</p><p>Comparison between mRECIST and EASL criteria for HCC<sup>10</sup>.</p
Objectives: To evaluate the inter-observer reliability of modified Response Evaluation Criteria In S...
There are unmet needs in evaluating treatment response of hepatocellular carcinoma in research proto...
Background: According to the Liver Imaging Reporting and Data System (LI-RADS), the LI-RADS category...
Radiological response assessment criteria in hepatocellular carcinoma (HCC) have evolved to accurate...
The European Association for the Study of the Liver (EASL) criteria and the modified Response Evalua...
The European Association for the Study of the Liver (EASL) criteria and the modified Response Evalua...
In 2010, modified RECIST (mRECIST) criteria were proposed as a way of adapting the RECIST criteria t...
Background The European Association for the Study of the Liver (EASL) criteria and the modified Resp...
Background The European Association for the Study of the Liver (EASL) criteria and the modified Resp...
International audienceThe Modified Response Evaluation Criteria in Solid Tumors (mRECIST) was develo...
The endpoint in cancer research is overall survival. Nonetheless, other potential surrogate endpoint...
BACKGROUND: Data comparing EASL and mRECIST criteria for response evaluation in treatment of hepatoc...
Background & Aims: The Modified Response Evaluation Criteria in Solid Tumors (mRECIST) was developed...
Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in...
Purpose: To assess response to programmed death-1 (PD-1) monotherapy (nivolumab) in hepatocellular c...
Objectives: To evaluate the inter-observer reliability of modified Response Evaluation Criteria In S...
There are unmet needs in evaluating treatment response of hepatocellular carcinoma in research proto...
Background: According to the Liver Imaging Reporting and Data System (LI-RADS), the LI-RADS category...
Radiological response assessment criteria in hepatocellular carcinoma (HCC) have evolved to accurate...
The European Association for the Study of the Liver (EASL) criteria and the modified Response Evalua...
The European Association for the Study of the Liver (EASL) criteria and the modified Response Evalua...
In 2010, modified RECIST (mRECIST) criteria were proposed as a way of adapting the RECIST criteria t...
Background The European Association for the Study of the Liver (EASL) criteria and the modified Resp...
Background The European Association for the Study of the Liver (EASL) criteria and the modified Resp...
International audienceThe Modified Response Evaluation Criteria in Solid Tumors (mRECIST) was develo...
The endpoint in cancer research is overall survival. Nonetheless, other potential surrogate endpoint...
BACKGROUND: Data comparing EASL and mRECIST criteria for response evaluation in treatment of hepatoc...
Background & Aims: The Modified Response Evaluation Criteria in Solid Tumors (mRECIST) was developed...
Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in...
Purpose: To assess response to programmed death-1 (PD-1) monotherapy (nivolumab) in hepatocellular c...
Objectives: To evaluate the inter-observer reliability of modified Response Evaluation Criteria In S...
There are unmet needs in evaluating treatment response of hepatocellular carcinoma in research proto...
Background: According to the Liver Imaging Reporting and Data System (LI-RADS), the LI-RADS category...